STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON

用于数据比较的嗜酸性粒细胞相关参数的标准值

基本信息

  • 批准号:
    7718523
  • 负责人:
  • 金额:
    $ 0.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Eosinophils are immune cells that develop in the bone marrow in response to interleukins-3, -5 (IL-3, IL-5) and granulocyte macrophage colony stimulating factor (GM-CSF). Mature eosinophils migrate to the gut and are involved in parasitic immunity, especially to helminthes. Eosinophils are also associated with many allergic diseases including asthma, atopic dermatitis, drug reactions and chronic urticaria. Eosinophil-associated gastrointestinal diseases include eosinophilic esophagitis, eosinophilic gastroenteritis and collagenous colitis. The hypereosinophilic syndrome includes patients with marked increases in eosinophils. The eosinophil is also involved in diseases caused by adulterated food products such as eosinophilia myalgia syndrome and toxic oil syndrome. Glucocorticoids have been used as a treatment for many of these diseases; however, long-term steroid usage causes significant side effects. Values for such assays can only be placed in meaningful context with comparison against normal patient values. Because of inter-laboratory variations in equipment, technique, and reagents, literature values will usually not suffice. It is necessary for each laboratory to establish normal values for the assays. Further, normal patient samples should be frequently run alongside study participant samples, in order to confirm that the equipment remains calibrated and technique unchanged. The objective of this project is to verify that equipment is consistently calibrated and working, as well as to obtain a range of normal values against which to compare patient samples for a number of present and future studies.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 嗜酸性粒细胞是响应白细胞介素-3、-5(IL-3、IL-5)和粒细胞巨噬细胞集落刺激因子(GM-CSF)在骨髓中发育的免疫细胞。 成熟的嗜酸性粒细胞迁移到肠道,参与寄生虫免疫,特别是蠕虫。 嗜酸性粒细胞也与许多过敏性疾病有关,包括哮喘、特应性皮炎、药物反应和慢性荨麻疹。嗜酸性粒细胞相关的胃肠道疾病包括嗜酸性粒细胞性食管炎、嗜酸性粒细胞性胃肠炎和胶原性结肠炎。嗜酸性粒细胞增多综合征包括嗜酸性粒细胞显著增加的患者。嗜酸性粒细胞也参与掺假食品引起的疾病,如嗜酸性粒细胞增多症、肌痛综合征和毒油综合征。糖皮质激素已被用作许多这些疾病的治疗方法;然而,长期使用类固醇会导致显着的副作用。 此类测定的值只能放在有意义的背景下与正常患者值进行比较。 由于实验室间设备、技术和试剂的差异,文献值通常是不够的。 每个实验室都有必要建立测定的正常值。 此外,正常患者样本应经常与研究参与者样本一起运行,以确认设备保持校准且技术不变。 本项目的目标是验证设备是否始终校准和工作,以及 获得一系列正常值,用于比较当前和未来研究的患者样本。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gerald J Gleich其他文献

Lidocaine may inhibit interleukin-5-induced signal transduction by blocking protein kinase C activity
  • DOI:
    10.1016/s0091-6749(02)82134-0
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jennifer L Bankers-Fulbright;Gail M Kephart;Matthew P Abdel;Patricia L Caffes;Kara Hurlihy;Gerald J Gleich
  • 通讯作者:
    Gerald J Gleich
VENOM IMMUNOTHERAPY FOR HONEYBEE STING-SENSITIVE PERSONS
针对对蜜蜂蜇刺敏感人群的毒液免疫疗法
  • DOI:
    10.1203/00006450-197704000-00761
  • 发表时间:
    1977-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    John W Yunginger;Barry R Paull;Gerald J Gleich;G S Gilchrist
  • 通讯作者:
    G S Gilchrist

Gerald J Gleich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gerald J Gleich', 18)}}的其他基金

Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
利用针对嗜酸性粒细胞颗粒主要碱性蛋白的中和剂开发治疗嗜酸性粒细胞介导的过敏性炎症疾病的方法
  • 批准号:
    10401936
  • 财政年份:
    2021
  • 资助金额:
    $ 0.04万
  • 项目类别:
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
利用针对嗜酸性粒细胞颗粒主要碱性蛋白的中和剂开发治疗嗜酸性粒细胞介导的过敏性炎症疾病的方法
  • 批准号:
    10257909
  • 财政年份:
    2021
  • 资助金额:
    $ 0.04万
  • 项目类别:
Novel, Non-InvasiveImaging of Eosinophil-Related Inflammation Throughout the Esophagus in Patients withEosinophilic Esophagitis
嗜酸性粒细胞性食管炎患者食管内嗜酸性粒细胞相关炎症的新型非侵入性成像
  • 批准号:
    10017684
  • 财政年份:
    2020
  • 资助金额:
    $ 0.04万
  • 项目类别:
TMEM103 in Eosinophil Development
TMEM103 在嗜酸性粒细胞发育中的作用
  • 批准号:
    7660267
  • 财政年份:
    2009
  • 资助金额:
    $ 0.04万
  • 项目类别:
TMEM103 in Eosinophil Development
TMEM103 在嗜酸性粒细胞发育中的作用
  • 批准号:
    7768508
  • 财政年份:
    2009
  • 资助金额:
    $ 0.04万
  • 项目类别:
CLINICAL TRIAL: ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
临床试验:艾替班特治疗遗传性血管性水肿
  • 批准号:
    7718517
  • 财政年份:
    2008
  • 资助金额:
    $ 0.04万
  • 项目类别:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
高嗜酸性粒细胞综合征和美泊利珠单抗
  • 批准号:
    7718504
  • 财政年份:
    2008
  • 资助金额:
    $ 0.04万
  • 项目类别:
ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
Icatibant 用于治疗遗传性血管性水肿
  • 批准号:
    7604975
  • 财政年份:
    2007
  • 资助金额:
    $ 0.04万
  • 项目类别:
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON
用于数据比较的嗜酸性粒细胞相关参数的标准值
  • 批准号:
    7604980
  • 财政年份:
    2007
  • 资助金额:
    $ 0.04万
  • 项目类别:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
高嗜酸性粒细胞综合征和美泊利珠单抗
  • 批准号:
    7604962
  • 财政年份:
    2007
  • 资助金额:
    $ 0.04万
  • 项目类别:

相似海外基金

Elucidation of the mechanisms of clothing-induced allergic symptoms and quantification of itching
阐明衣服引起的过敏症状的机制和瘙痒的量化
  • 批准号:
    23H00914
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism of Retinal Choroidal Inflammation in Chronic Severe Allergic Conjunctivitis
慢性重症过敏性结膜炎视网膜脉络膜炎症机制
  • 批准号:
    23K15918
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
  • 批准号:
    10664599
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
Gut Microbial Factors in Farming Lifestyle and Allergic Sensitization
农业生活方式和过敏致敏中的肠道微生物因素
  • 批准号:
    10633368
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
Role of Skin Barrier and Immune Alterations in Allergic Sensitization
皮肤屏障和免疫改变在过敏性致敏中的作用
  • 批准号:
    10633370
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
Elucidation of the mechanisms by which paired immune receptors recognize their ligands and development of treatments for allergic and inflammatory diseases
阐明配对免疫受体识别其配体的机制并开发过敏性和炎症性疾病的治疗方法
  • 批准号:
    23H02946
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic analysis of the pathogenesis of atopic dermatitis focusing on the allergic sensitivity of NC mice.
以NC小鼠过敏敏感性为重点的特应性皮炎发病机制的遗传分析。
  • 批准号:
    23K05600
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relationship between changes in intestinal microflora and anti-allergic effects caused by ingestion of koji-fermented soybeans
摄入曲发酵大豆引起的肠道菌群变化与抗过敏作用的关系
  • 批准号:
    23K02043
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
  • 批准号:
    10600767
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
The effects of wildfire exposure on maternal allergic asthma and consequences on neurobiology
野火暴露对母亲过敏性哮喘的影响及其对神经生物学的影响
  • 批准号:
    10727122
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了